FDA Inspection 1084645 — Swiss Pharmaceutical Company Ltd

Swiss Pharmaceutical Company Ltd — FEI 3011773475

The FDA completed an inspection of Swiss Pharmaceutical Company Ltd on March 22, 2019 in Tai Nan Shi. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 22, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tai Nan Shi (Taiwan)

Citations

IDCFRDescription
125621 CFR 211.68(b)Backup file not maintained
127021 CFR 211.68(b)input/output verification